New bronchitis drug shows promise in early trial
NCT ID NCT07061925
First seen Jan 11, 2026 · Last updated May 13, 2026 · Updated 17 times
Summary
This study tested a new medicine called ALC-2203 in 169 adults with acute bronchitis. The goal was to see if it reduces symptoms like cough and chest pain better than a placebo or another active drug. Participants took the medicine for a week, and doctors checked their symptom scores on days 4 and 7.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE BRONCHITIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Konkuk University Medical Center
Seoul, 05030, South Korea
Conditions
Explore the condition pages connected to this study.